Qiagen End Period Cash Flow vs Ev To Free Cash Flow Analysis

QGEN Stock

USD 43.24 0.01 0.02%

Qiagen NV financial indicator trend analysis is much more than just breaking down Qiagen NV prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Qiagen NV is a good investment. Please check the relationship between Qiagen NV End Period Cash Flow and its Ev To Free Cash Flow accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.

End Period Cash Flow vs Ev To Free Cash Flow

End Period Cash Flow vs Ev To Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Qiagen NV End Period Cash Flow account and Ev To Free Cash Flow. At this time, the significance of the direction appears to have no relationship.

The correlation between Qiagen NV's End Period Cash Flow and Ev To Free Cash Flow is 0.0. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Ev To Free Cash Flow in the same time period over historical financial statements of Qiagen NV, assuming nothing else is changed. The correlation between historical values of Qiagen NV's End Period Cash Flow and Ev To Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Qiagen NV are associated (or correlated) with its Ev To Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Free Cash Flow has no effect on the direction of End Period Cash Flow i.e., Qiagen NV's End Period Cash Flow and Ev To Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.0

Relationship Direction	Flat
Relationship Strength	Insignificant

View All Relationships

End Period Cash Flow

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Most indicators from Qiagen NV's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Qiagen NV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.At this time, Qiagen NV's Selling General Administrative is very stable compared to the past year. As of the 26th of November 2024, Enterprise Value Over EBITDA is likely to grow to 29.48, while Tax Provision is likely to drop about 46.7 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.5B	1.4B	1.2B	664.0M
Total Revenue	2.3B	2.1B	2.0B	1.0B

Gross Profit Total Revenue

Qiagen NV fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Short Term Investments	Intangible Assets	Common Stock Total Equity
Total Assets		0.91	0.73	0.62	0.69	0.62	0.89	0.46	0.89	0.81	0.97	0.55	0.72	0.73	0.79	0.79	0.58	0.7	0.85	0.91	0.77	0.43	0.83	0.46	0.53	0.82
Short Long Term Debt Total	0.91		0.71	0.64	0.49	0.52	0.95	0.33	0.84	0.92	0.82	0.75	0.81	0.69	0.57	0.89	0.52	0.68	0.62	0.99	0.81	0.47	0.58	0.47	0.26	0.57
Other Current Liab	0.73	0.71		0.85	0.62	0.59	0.63	0.47	0.75	0.71	0.66	0.3	0.68	0.74	0.51	0.49	0.58	0.65	0.63	0.73	0.75	0.68	0.53	0.37	0.31	0.53
Total Current Liabilities	0.62	0.64	0.85		0.66	0.76	0.52	0.69	0.67	0.71	0.49	0.2	0.77	0.78	0.3	0.32	0.81	0.8	0.34	0.63	0.86	0.95	0.33	0.52	0.06	0.35
Total Stockholder Equity	0.69	0.49	0.62	0.66		0.94	0.45	0.88	0.56	0.48	0.67	0.12	0.68	0.86	0.74	0.35	0.81	0.66	0.66	0.48	0.79	0.57	0.76	0.6	0.46	0.79
Property Plant And Equipment Net	0.62	0.52	0.59	0.76	0.94		0.47	0.94	0.56	0.51	0.55	0.15	0.75	0.91	0.52	0.35	0.93	0.74	0.45	0.5	0.87	0.71	0.56	0.68	0.22	0.59
Net Debt	0.89	0.95	0.63	0.52	0.45	0.47		0.27	0.88	0.76	0.84	0.72	0.68	0.65	0.57	0.93	0.5	0.68	0.65	0.97	0.71	0.31	0.59	0.43	0.35	0.58
Retained Earnings	0.46	0.33	0.47	0.69	0.88	0.94	0.27		0.38	0.38	0.36	-0.05	0.7	0.73	0.36	0.11	0.9	0.69	0.29	0.29	0.79	0.7	0.41	0.79	0.06	0.44
Accounts Payable	0.89	0.84	0.75	0.67	0.56	0.56	0.88	0.38		0.68	0.86	0.49	0.61	0.69	0.57	0.77	0.66	0.81	0.69	0.9	0.71	0.46	0.61	0.38	0.5	0.6
Cash	0.81	0.92	0.71	0.71	0.48	0.51	0.76	0.38	0.68		0.68	0.68	0.87	0.64	0.5	0.71	0.48	0.59	0.49	0.87	0.82	0.62	0.49	0.46	0.1	0.48
Non Current Assets Total	0.97	0.82	0.66	0.49	0.67	0.55	0.84	0.36	0.86	0.68		0.49	0.55	0.69	0.88	0.77	0.48	0.59	0.93	0.85	0.63	0.28	0.91	0.29	0.7	0.9
Non Currrent Assets Other	0.55	0.75	0.3	0.2	0.12	0.15	0.72	-0.05	0.49	0.68	0.49		0.56	0.32	0.37	0.86	0.14	0.33	0.32	0.75	0.47	0.06	0.29	0.26	0.08	0.29
Cash And Short Term Investments	0.72	0.81	0.68	0.77	0.68	0.75	0.68	0.7	0.61	0.87	0.55	0.56		0.72	0.42	0.6	0.73	0.76	0.37	0.75	0.97	0.71	0.41	0.81	-0.03	0.43
Net Receivables	0.73	0.69	0.74	0.78	0.86	0.91	0.65	0.73	0.69	0.64	0.69	0.32	0.72		0.62	0.56	0.83	0.67	0.59	0.69	0.85	0.66	0.64	0.45	0.36	0.67
Common Stock Shares Outstanding	0.79	0.57	0.51	0.3	0.74	0.52	0.57	0.36	0.57	0.5	0.88	0.37	0.42	0.62		0.6	0.32	0.35	0.93	0.6	0.48	0.12	0.98	0.19	0.8	0.98
Non Current Liabilities Total	0.79	0.89	0.49	0.32	0.35	0.35	0.93	0.11	0.77	0.71	0.77	0.86	0.6	0.56	0.6		0.34	0.51	0.6	0.92	0.6	0.1	0.56	0.31	0.4	0.55
Inventory	0.58	0.52	0.58	0.81	0.81	0.93	0.5	0.9	0.66	0.48	0.48	0.14	0.73	0.83	0.32	0.34		0.88	0.31	0.52	0.86	0.76	0.37	0.71	0.13	0.4
Other Current Assets	0.7	0.68	0.65	0.8	0.66	0.74	0.68	0.69	0.81	0.59	0.59	0.33	0.76	0.67	0.35	0.51	0.88		0.37	0.7	0.84	0.71	0.37	0.72	0.19	0.38
Other Stockholder Equity	0.85	0.62	0.63	0.34	0.66	0.45	0.65	0.29	0.69	0.49	0.93	0.32	0.37	0.59	0.93	0.6	0.31	0.37		0.65	0.45	0.12	0.96	0.15	0.79	0.95
Total Liab	0.91	0.99	0.73	0.63	0.48	0.5	0.97	0.29	0.9	0.87	0.85	0.75	0.75	0.69	0.6	0.92	0.52	0.7	0.65		0.77	0.44	0.59	0.4	0.36	0.59
Total Current Assets	0.77	0.81	0.75	0.86	0.79	0.87	0.71	0.79	0.71	0.82	0.63	0.47	0.97	0.85	0.48	0.6	0.86	0.84	0.45	0.77		0.77	0.49	0.77	0.1	0.51
Short Term Debt	0.43	0.47	0.68	0.95	0.57	0.71	0.31	0.7	0.46	0.62	0.28	0.06	0.71	0.66	0.12	0.1	0.76	0.71	0.12	0.44	0.77		0.16	0.5	-0.14	0.18
Common Stock	0.83	0.58	0.53	0.33	0.76	0.56	0.59	0.41	0.61	0.49	0.91	0.29	0.41	0.64	0.98	0.56	0.37	0.37	0.96	0.59	0.49	0.16		0.21	0.78	1.0
Short Term Investments	0.46	0.47	0.37	0.52	0.6	0.68	0.43	0.79	0.38	0.46	0.29	0.26	0.81	0.45	0.19	0.31	0.71	0.72	0.15	0.4	0.77	0.5	0.21		-0.18	0.23
Intangible Assets	0.53	0.26	0.31	0.06	0.46	0.22	0.35	0.06	0.5	0.1	0.7	0.08	-0.03	0.36	0.8	0.4	0.13	0.19	0.79	0.36	0.1	-0.14	0.78	-0.18		0.77
Common Stock Total Equity	0.82	0.57	0.53	0.35	0.79	0.59	0.58	0.44	0.6	0.48	0.9	0.29	0.43	0.67	0.98	0.55	0.4	0.38	0.95	0.59	0.51	0.18	1.0	0.23	0.77

Click cells to compare fundamentals

Qiagen NV Account Relationship Matchups

Qiagen NV fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	5.2B	6.0B	6.1B	6.3B	6.1B	3.2B
Short Long Term Debt Total	1.7B	2.0B	1.9B	1.9B	1.6B	903.4M
Other Current Liab	532.8M	273.3M	455.5M	381.0M	306.0M	321.3M
Total Current Liabilities	951.3M	613.8M	1.5B	974.5M	1.1B	1.1B
Total Stockholder Equity	2.5B	2.5B	3.1B	3.5B	3.8B	4.0B
Property Plant And Equipment Net	455.2M	528.6M	638.2M	662.2M	870.3M	913.8M
Net Debt	1.1B	1.4B	1.1B	1.1B	943.0M	494.1M
Retained Earnings	868.8M	758.5M	1.5B	2.2B	2.5B	2.6B
Accounts Payable	84.8M	118.2M	101.2M	98.7M	84.2M	48.7M
Cash	623.6M	597.0M	880.5M	730.7M	668.1M	409.2M
Non Current Assets Total	3.7B	4.3B	4.0B	3.9B	4.0B	2.2B
Non Currrent Assets Other	188.4M	423.8M	157.6M	254.4M	65.3M	109.0M
Cash And Short Term Investments	753.2M	714.3M	1.1B	1.4B	1.1B	1.1B
Net Receivables	427.2M	439.9M	469.7M	333.5M	515.6M	541.4M
Common Stock Shares Outstanding	220.0M	227.2M	225.1M	223.2M	223.7M	202.8M
Liabilities And Stockholders Equity	5.2B	6.0B	6.1B	6.3B	6.1B	3.2B
Non Current Liabilities Total	1.7B	2.9B	1.5B	1.8B	1.2B	1.0B
Inventory	170.7M	291.2M	327.5M	358.0M	398.4M	418.3M
Other Current Assets	105.5M	204.3M	247.1M	284.2M	175.8M	184.5M
Other Stockholder Equity	2.0B	1.7B	1.6B	1.7B	1.8B	1.1B
Total Liab	2.7B	3.5B	3.1B	2.8B	2.3B	1.4B
Total Current Assets	1.6B	1.6B	2.1B	2.4B	2.1B	2.3B
Accumulated Other Comprehensive Income	(309.6M)	(239.6M)	(326.7M)	(404.1M)	(433.8M)	(412.1M)
Short Term Debt	285.2M	66.0M	869.7M	411.8M	610.2M	640.7M
Short Term Investments	129.6M	117.2M	184.8M	687.6M	389.7M	409.2M
Intangible Assets	632.4M	883.6M	627.4M	544.8M	526.8M	465.5M
Other Liab	280.9M	516.4M	438.8M	411.9M	473.7M	497.4M
Current Deferred Revenue	48.5M	57.1M	63.4M	69M	66.4M	63.1M
Other Assets	294.9M	468.6M	421.0M	269.6M	1.0	0.95
Long Term Debt	1.4B	1.9B	1.1B	1.5B	921.8M	936.7M
Property Plant Equipment	512.5M	661.9M	638.2M	586.6M	674.5M	406.3M
Good Will	2.1B	2.4B	2.4B	2.4B	2.5B	2.3B
Long Term Investments	75.5M	87.1M	15.4M	23.5M	21.2M	39.6M
Short Long Term Debt	285.2M	42.5M	847.6M	389.6M	588.0M	418.6M
Net Tangible Assets	(236.3M)	(292.4M)	118.4M	293.6M	337.6M	354.5M

Pair Trading with Qiagen NV

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Qiagen NV position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qiagen NV will appreciate offsetting losses from the drop in the long position's value.

Moving together with Qiagen Stock

0.66	A	Agilent Technologies Sell-off Trend	Pair Corr
0.76	ME	23Andme Holding	Pair Corr
0.68	VALN	Valneva SE ADR	Pair Corr

Moving against Qiagen Stock

0.76	EWTX	Edgewise Therapeutics	Pair Corr
0.72	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.56	EXEL	Exelixis	Pair Corr
0.5	FLGC	Flora Growth Corp	Pair Corr
0.46	KTTAW	Pasithea Therapeutics	Pair Corr

The ability to find closely correlated positions to Qiagen NV could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Qiagen NV when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Qiagen NV - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Qiagen NV to buy it.

The correlation of Qiagen NV is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Qiagen NV moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Qiagen NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Qiagen NV can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Qiagen NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Qiagen NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Qiagen Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Qiagen Nv Stock:

How To Invest In Qiagen

Details

Is Qiagen Stock a good investment?

Details

What is Qiagen NV's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qiagen NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Qiagen Stock, please use our How to Invest in Qiagen NV guide.

You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qiagen NV. If investors know Qiagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qiagen NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.255

Earnings Share

0.44

Revenue Per Share

8.841

Quarterly Revenue Growth

0.055

Return On Assets

0.0484

The market value of Qiagen NV is measured differently than its book value, which is the value of Qiagen that is recorded on the company's balance sheet. Investors also form their own opinion of Qiagen NV's value that differs from its market value or its book value, called intrinsic value, which is Qiagen NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qiagen NV's market value can be influenced by many factors that don't directly affect Qiagen NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Qiagen NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Qiagen NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qiagen NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Qiagen End Period Cash Flow vs Ev To Free Cash Flow Analysis

End Period Cash Flow vs Ev To Free Cash Flow

End Period Cash Flow vs Ev To Free Cash Flow Correlation Analysis

Correlation Coefficient

End Period Cash Flow

Ev To Free Cash Flow

Qiagen NV fundamental ratios Correlations

Qiagen NV Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Qiagen NV fundamental ratios Accounts

Pair Trading with Qiagen NV

Moving together with Qiagen Stock

Moving against Qiagen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 1.0	Common Stock
Total Liab	+ 0.99	Short Long Term Debt Total
Common Stock	+ 0.98	Common Stock Shares Outstanding
Common Stock Total Equity	+ 0.98	Common Stock Shares Outstanding
Non Current Assets Total	+ 0.97	Total Assets
Total Liab	+ 0.97	Net Debt

Intangible Assets	- 0.18	Short Term Investments
Intangible Assets	- 0.14	Short Term Debt
Non Currrent Assets Other	- 0.05	Retained Earnings
Intangible Assets	- 0.03	Cash And Short Term Investments